FFO
EBS icon

Fortitude Family Office’s Emergent Biosolutions EBS Stock Holding History

Fortitude Family Office’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-108
Closed -$896 – 2299
2026
Q1 		$896 Buy
+108
New +$1.12K ﹤0.01% 1532
2025
Q3 		– Sell
-74
Closed -$472 – 2027
2025
Q2 		$472 Buy
+74
New +$423 ﹤0.01% 1841

Other funds holding EBS

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
BWM
Baron Wealth Management Troy, Michigan $386M AUM 30.18% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HA
Herold Advisors New York $506M AUM 26.75% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Fortitude Family Office's EBS Position: Q2 2026 in Review

Fortitude Family Office sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 108 shares — an estimated $896 sold.

Fortitude Family Office first reported a position in EBS in Q2 2025 and held it in 2 quarters. The position peaked at $896 in Q1 2026. 29 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Fortitude Family Office reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 108 Emergent Biosolutions shares in Q2 2026, an estimated $896.
  • Fortitude Family Office first reported a position in Emergent Biosolutions in Q2 2025 and held it in 2 quarters.
  • Fortitude Family Office's Emergent Biosolutions position peaked at $896 in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.